Consequently, application of the SCD1 inhibitor, MF-438, abolished the resistance of melanoma spheroids to these drugs, with simultaneous decreases in the expression of YAP/TAZ and stem cell markers [87]. This evidence concerns the gene TAFAZZIN and melanoma.